Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR –Preserved trial

Author:

Pocock Stuart J.1,Ferreira João Pedro23ORCID,Packer Milton45,Zannad Faiez3,Filippatos Gerasimos6,Kondo Toru78,McMurray John J.V.8,Solomon Scott D.9,Januzzi James L.10,Iwata Tomoko11,Salsali Afshin11,Butler Javed1213,Anker Stefan D.14

Affiliation:

1. Department of Medical Statistics London School of Hygiene and Tropical Medicine London UK

2. UnIC@Rise, Department of Surgery and Physiology, Faculty of Medicine, Cardiovascular Research and Development Center University of Porto Porto Portugal

3. Inserm, Centre d'Investigations Cliniques Plurithématique 1433, and Inserm U1116, CHRU, F‐CRIN INI‐CRCT (Cardiovascular and Renal Clinical Trialists) Université de Lorraine Nancy France

4. Baylor Heart and Vascular Hospital Baylor University Medical Center Dallas TX USA

5. Imperial College London UK

6. National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology Attikon University Hospital Athens Greece

7. Department of Cardiology Nagoya University Graduate School of Medicine Nagoya Japan

8. British Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UK

9. Cardiovascular Division, Brigham and Women's Hospital Harvard Medical School Boston MA USA

10. Massachusetts General Hospital Harvard Medical School Boston MA USA

11. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany

12. Baylor Scott and White Research Institute Dallas TX USA

13. Department of Medicine University of Mississippi Medical Center Jackson MS USA

14. Department of Cardiology, and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin Charité Universitätsmedizin Berlin Germany

Funder

Boehringer Ingelheim

Eli Lilly and Company

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3